Search research articles
Contact Us
Filters
Showing results (591-600 of 630) with videos related to
Page
of 63
Sort By:
European Heart Journal. Quality of Care & Clinical Outcomes
|
October 19, 2017
Duration of dual antiplatelet therapy and associated outcomes following percutaneous coronary intervention for acute myocardial infarction: contemporary practice insights from the Canadian Observational Antiplatelet Study
Juan J Russo, Shaun G Goodman, Akshay Bagai, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 23, 2006
Substituted N-(2-aminophenyl)-benzamides, (E)-N-(2-aminophenyl)-acrylamides and their analogues: novel classes of histone deacetylase inhibitors
Oscar Moradei, Silvana Leit, Nancy Zhou, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance
|
December 7, 2023
Post-COVID-19 vaccination myocarditis: a prospective cohort study pre and post vaccination using cardiovascular magnetic resonance
Ming-Yen Ng, Cheuk Hang Tam, Yung Pok Lee, et al.
The Canadian Journal of Cardiology
|
December 6, 2014
Increased uptake of guideline-recommended oral antiplatelet therapy: insights from the Canadian acute coronary syndrome reflective
Sumeet Gandhi, Brigita Zile, Mary K Tan, et al.
Circulation
|
August 23, 2019
Effect of Empagliflozin on Left Ventricular Mass in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease: The EMPA-HEART CardioLink-6 Randomized Clinical Trial
Subodh Verma, C David Mazer, Andrew T Yan, et al.
Journal of Medicinal Chemistry
|
June 24, 2008
Discovery of N-(2-aminophenyl)-4-[(4-pyridin-3-ylpyrimidin-2-ylamino)methyl]benzamide (MGCD0103), an orally active histone deacetylase inhibitor
Nancy Zhou, Oscar Moradei, Stephane Raeppel, et al.
JAMA Cardiology
|
April 12, 2023
Comprehensive Cardiovascular Magnetic Resonance Tissue Characterization and Cardiotoxicity in Women With Breast Cancer
Paaladinesh Thavendiranathan, Tamar Shalmon, Chun-Po Steve Fan, et al.
Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi
|
December 1, 2025
[Application of multidisciplinary team diagnosis and treatment model in the management of patients with combined burns and heat stroke]
S S Jiang, N N Wang, H H Wang, et al.
Internal Medicine Journal
|
March 1, 2019
Extended dual antiplatelet therapy for Asian patients with acute coronary syndrome: expert recommendations
Walter W C Chen, Kwan-Kin Law, Shu-Kin Li, et al.
American Heart Journal
|
September 24, 2016
Ischemic and bleeding events in patients with myocardial infarction undergoing percutaneous coronary intervention who require oral anticoagulation: Insights from the Canadian observational AntiPlatelet sTudy
Steven Sra, Mary K Tan, Shamir R Mehta, et al.
Page
of 63
Search research articles
Search
Showing results (591-600 of 630) with videos related to
Sort By:
Page
of 63
European Heart Journal. Quality of Care & Clinical Outcomes
|
October 19, 2017
Duration of dual antiplatelet therapy and associated outcomes following percutaneous coronary intervention for acute myocardial infarction: contemporary practice insights from the Canadian Observational Antiplatelet Study
Juan J Russo, Shaun G Goodman, Akshay Bagai, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 23, 2006
Substituted N-(2-aminophenyl)-benzamides, (E)-N-(2-aminophenyl)-acrylamides and their analogues: novel classes of histone deacetylase inhibitors
Oscar Moradei, Silvana Leit, Nancy Zhou, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance
|
December 7, 2023
Post-COVID-19 vaccination myocarditis: a prospective cohort study pre and post vaccination using cardiovascular magnetic resonance
Ming-Yen Ng, Cheuk Hang Tam, Yung Pok Lee, et al.
The Canadian Journal of Cardiology
|
December 6, 2014
Increased uptake of guideline-recommended oral antiplatelet therapy: insights from the Canadian acute coronary syndrome reflective
Sumeet Gandhi, Brigita Zile, Mary K Tan, et al.
Circulation
|
August 23, 2019
Effect of Empagliflozin on Left Ventricular Mass in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease: The EMPA-HEART CardioLink-6 Randomized Clinical Trial
Subodh Verma, C David Mazer, Andrew T Yan, et al.
Journal of Medicinal Chemistry
|
June 24, 2008
Discovery of N-(2-aminophenyl)-4-[(4-pyridin-3-ylpyrimidin-2-ylamino)methyl]benzamide (MGCD0103), an orally active histone deacetylase inhibitor
Nancy Zhou, Oscar Moradei, Stephane Raeppel, et al.
JAMA Cardiology
|
April 12, 2023
Comprehensive Cardiovascular Magnetic Resonance Tissue Characterization and Cardiotoxicity in Women With Breast Cancer
Paaladinesh Thavendiranathan, Tamar Shalmon, Chun-Po Steve Fan, et al.
Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi
|
December 1, 2025
[Application of multidisciplinary team diagnosis and treatment model in the management of patients with combined burns and heat stroke]
S S Jiang, N N Wang, H H Wang, et al.
Internal Medicine Journal
|
March 1, 2019
Extended dual antiplatelet therapy for Asian patients with acute coronary syndrome: expert recommendations
Walter W C Chen, Kwan-Kin Law, Shu-Kin Li, et al.
American Heart Journal
|
September 24, 2016
Ischemic and bleeding events in patients with myocardial infarction undergoing percutaneous coronary intervention who require oral anticoagulation: Insights from the Canadian observational AntiPlatelet sTudy
Steven Sra, Mary K Tan, Shamir R Mehta, et al.
Page
of 63